An IAEA project to transfer disused radium sources for use in cancer treatment has now conducted nearly a dozen international transfers. Working in partnership with the IAEA, Tunisia completed the ...
A phase 2 trial showed that olaparib plus radium 223 prolonged progression-free survival in a subset of patients with castration-resistant prostate cancer and bone metastases. Radiographic progression ...
XOFIGO® (radium-223 dichloride) in combination with enzalutamide significantly increased radiological progression-free survival (rPFS) for patients with metastatic castration-resistant prostate cancer ...
Revisiting Radium-223 in Oligometastatic Castration-Sensitive Prostate Cancer: RAVENS Trial Insights
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
The IAEA’s programme to foster cooperation between countries with disused radium-226 sources and those with the means to recycle or reuse them had a productive year, according to a technical meeting ...
Adding radium-223 dichloride (Ra223) to metastasis-directed stereotactic ablative radiotherapy (SABR) did not improve progression-free survival compared with SABR alone in men with bone-only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results